$627 Million is the total value of First Light Asset Management, LLC's 59 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was 27.1% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ARRY | Buy | ARRAY BIOPHARMA INC | $40,667,000 | +12.4% | 2,853,826 | +19.9% | 6.48% | +11.0% |
OMCL | Sell | OMNICELL INC | $40,459,000 | -15.1% | 660,655 | -0.4% | 6.45% | -16.1% |
SPNE | New | SEASPINE HOLDINGS CORP | $32,560,000 | – | 1,785,071 | +100.0% | 5.19% | – |
OXFD | Buy | OXFORD IMMUNOTEC GLOBAL PLC | $32,136,000 | +24.2% | 2,514,552 | +57.8% | 5.12% | +22.8% |
IONS | Buy | IONIS PHARMACEUTICALS INC | $31,896,000 | +25.6% | 590,010 | +19.9% | 5.08% | +24.1% |
ATRC | Sell | ATRICURE INC | $29,553,000 | -13.0% | 965,797 | -0.4% | 4.71% | -14.0% |
SHPG | Sell | SHIRE PLC | $28,440,000 | -31.4% | 163,409 | -28.5% | 4.53% | -32.2% |
NEO | Sell | NEOGENOMICS INC | $27,845,000 | -51.0% | 2,208,188 | -40.3% | 4.44% | -51.6% |
NKTR | Buy | NEKTAR THERAPEUTICS | $24,003,000 | +5.7% | 730,226 | +96.0% | 3.83% | +4.4% |
MODN | Buy | MODEL N INC | $22,840,000 | +8.0% | 1,726,404 | +29.4% | 3.64% | +6.7% |
HBIO | Buy | HARVARD BIOSCIENCE INC | $22,290,000 | -32.3% | 7,009,586 | +11.8% | 3.55% | -33.1% |
HRTX | Sell | HERON THERAPEUTICS INC | $21,407,000 | -18.8% | 825,269 | -0.9% | 3.41% | -19.8% |
XENT | Buy | INTERSECT ENT INC | $19,765,000 | +32.9% | 701,398 | +35.6% | 3.15% | +31.3% |
IMMU | Buy | IMMUNOMEDICS INC | $19,411,000 | -19.1% | 1,360,280 | +18.1% | 3.10% | -20.0% |
VCYT | Buy | VERACYTE INC | $19,164,000 | +69.0% | 1,523,405 | +28.3% | 3.06% | +66.9% |
NVTRQ | Buy | NUVECTRA CORP | $18,994,000 | +125.7% | 1,162,451 | +203.6% | 3.03% | +123.0% |
CDXS | Buy | CODEXIS INC | $17,691,000 | +23.2% | 1,059,359 | +26.5% | 2.82% | +21.7% |
XNCR | Sell | XENCOR INC | $16,842,000 | -7.6% | 465,770 | -0.4% | 2.68% | -8.7% |
CSII | Sell | CARDIOVASCULAR SYSTEMS INC | $13,735,000 | -27.6% | 482,104 | -0.5% | 2.19% | -28.4% |
HALO | Buy | HALOZYME THERAPEUTICS INC | $13,729,000 | -14.7% | 938,399 | +6.0% | 2.19% | -15.7% |
LGND | Buy | LIGAND PHARMACEUTICALS INC | $12,808,000 | -36.1% | 94,382 | +29.3% | 2.04% | -36.9% |
KRMD | New | REPRO MED SYSTEMS INC | $11,301,000 | – | 6,848,900 | +100.0% | 1.80% | – |
TNDM | TANDEM DIABETES CARE INC | $10,020,000 | -11.4% | 263,883 | 0.0% | 1.60% | -12.4% | |
ADRO | New | ADURO BIOTECH INC | $9,422,000 | – | 3,568,955 | +100.0% | 1.50% | – |
VAPO | New | VAPOTHERM INC | $6,075,000 | – | 304,509 | +100.0% | 0.97% | – |
OSUR | New | ORASURE TECHNOLOGIES INC | $5,983,000 | – | 512,216 | +100.0% | 0.95% | – |
BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $5,266,000 | -12.8% | 61,839 | -0.7% | 0.84% | -13.8% |
LHCG | Sell | LHC GROUP INC | $5,031,000 | -9.4% | 53,587 | -0.7% | 0.80% | -10.5% |
ALKS | Buy | ALKERMES PLC | $5,032,000 | +270.3% | 170,533 | +432.4% | 0.80% | +266.2% |
SLP | Buy | SIMULATIONS PLUS INC | $4,997,000 | +330.0% | 251,105 | +336.3% | 0.80% | +326.2% |
TRUP | New | TRUPANION INC | $4,883,000 | – | 191,808 | +100.0% | 0.78% | – |
MYL | New | MYLAN N V | $4,581,000 | – | 167,187 | +100.0% | 0.73% | – |
GMED | Sell | GLOBUS MEDICAL INC | $4,467,000 | -24.3% | 103,217 | -0.7% | 0.71% | -25.2% |
TEVA | New | TEVA PHARMACEUTICAL IND | $4,327,000 | – | 280,607 | +100.0% | 0.69% | – |
KIDS | Sell | ORTHOPEDIATRICS CORP | $4,269,000 | -5.5% | 122,394 | -0.7% | 0.68% | -6.6% |
VRTX | Sell | VERTEX PHARMACEUTICALS INC | $4,079,000 | -14.6% | 24,615 | -0.7% | 0.65% | -15.7% |
TECH | Sell | BIO TECHNE CORP | $3,625,000 | -29.6% | 25,048 | -0.7% | 0.58% | -30.4% |
BLUE | Sell | BLUEBIRD BIO INC | $3,274,000 | -32.5% | 33,002 | -0.6% | 0.52% | -33.3% |
DVAX | Sell | DYNAVAX TECHNOLOGIES CORP | $3,160,000 | -53.4% | 345,339 | -36.8% | 0.50% | -53.9% |
NXTM | Sell | NXSTAGE MEDICAL INC | $2,817,000 | -33.2% | 98,411 | -34.9% | 0.45% | -34.0% |
QDEL | Sell | QUIDEL CORP | $2,661,000 | -25.6% | 54,511 | -0.7% | 0.42% | -26.5% |
HSTM | Sell | HEALTHSTREAM INC | $2,179,000 | -22.8% | 90,210 | -0.9% | 0.35% | -23.7% |
IBB | ISHARES NASDAQ BIOTECHNOLOGY ETFetf | $2,053,000 | -20.9% | 21,291 | 0.0% | 0.33% | -22.0% | |
TLGT | Buy | TELIGENT INC | $2,008,000 | -55.6% | 1,465,569 | +28.0% | 0.32% | -56.2% |
PSCH | INVESCO SMALLCAP HEALTH CARE ETFetf | $1,859,000 | -23.4% | 17,285 | 0.0% | 0.30% | -24.3% | |
XLV | HEALTH CARE SELECT SECTOR SPDR ETFetf | $1,578,000 | -9.1% | 18,241 | 0.0% | 0.25% | -10.0% | |
IHI | ISHARES US MEDICAL DEVICES ETFetf | $1,515,000 | -12.1% | 7,580 | 0.0% | 0.24% | -12.9% | |
LMAT | Sell | LEMAITRE VASCULAR INC | $1,163,000 | -39.5% | 49,217 | -0.8% | 0.18% | -40.3% |
CLLS | Sell | CELLECTIS SA | $437,000 | -79.7% | 26,234 | -65.6% | 0.07% | -79.9% |
ABBV | ABBVIE | $383,000 | -2.5% | 4,159 | 0.0% | 0.06% | -3.2% | |
PFE | PFIZER INC | $374,000 | -0.8% | 8,558 | 0.0% | 0.06% | -1.6% | |
MRK | MERCK & CO INC | $328,000 | +7.5% | 4,294 | 0.0% | 0.05% | +6.1% | |
NVS | NOVARTIS A G | $307,000 | -0.3% | 3,572 | 0.0% | 0.05% | -2.0% | |
DYNT | Buy | DYNATRONICS CORP | $308,000 | -2.5% | 112,704 | +1.7% | 0.05% | -3.9% |
SNY | SANOFI-SYNTHELABO | $292,000 | -2.7% | 6,720 | 0.0% | 0.05% | -2.1% | |
JNJ | JOHNSON AND JOHNSON | $282,000 | -6.6% | 2,183 | 0.0% | 0.04% | -8.2% | |
ANTM | ANTHEM INC COM | $211,000 | -4.1% | 803 | 0.0% | 0.03% | -2.9% | |
AMGN | AMGEN INC | $215,000 | -6.1% | 1,105 | 0.0% | 0.03% | -8.1% | |
TFX | TELEFLEX INCORPORATED | $202,000 | -2.9% | 783 | 0.0% | 0.03% | -5.9% | |
STRM | Exit | STREAMLINE HEALTH SOLUTIONS | $0 | – | -39,701 | -100.0% | -0.01% | – |
HRC | Exit | HILL-ROM HOLDINGS INC | $0 | – | -2,144 | -100.0% | -0.03% | – |
HCA | Exit | HCA HOLDINGS INC | $0 | – | -1,513 | -100.0% | -0.03% | – |
PKI | Exit | PERKINELMER INC | $0 | – | -2,270 | -100.0% | -0.04% | – |
ENZ | Exit | ENZO BIOCHEM INC | $0 | – | -188,159 | -100.0% | -0.12% | – |
RMED | Exit | RA Medical Systems, Inc. | $0 | – | -60,000 | -100.0% | -0.18% | – |
SGMO | Exit | SANGAMO THERAPEUTICS INC | $0 | – | -265,877 | -100.0% | -0.73% | – |
KTWO | Exit | K2M GROUP HOLDINGS INC | $0 | – | -289,756 | -100.0% | -1.28% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-02-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ATRICURE INC | 40 | Q3 2023 | 9.7% |
NEOGENOMICS INC | 40 | Q3 2023 | 10.6% |
SANOFI-SYNTHELABO | 40 | Q3 2023 | 1.9% |
JOHNSON & JOHNSON | 40 | Q3 2023 | 0.3% |
PFIZER INC | 39 | Q2 2023 | 0.9% |
BIOMARIN PHARMACEUTICAL INC | 36 | Q3 2023 | 1.6% |
OMNICELL INC | 33 | Q3 2023 | 7.7% |
QUIDEL CORP | 33 | Q4 2021 | 3.7% |
NOVARTIS AG-SPONSORED ADR | 33 | Q3 2023 | 0.4% |
MODEL N INC | 30 | Q3 2023 | 9.0% |
View First Light Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
REATA PHARMACEUTICALS INC | May 15, 2023 | 1,290,193 | 3.9% |
Axogen, Inc. | February 03, 2023 | 1,942,270 | 4.6% |
MODEL N, INC. | February 03, 2023 | 1,845,134 | 4.9% |
MEI Pharma, Inc.Sold out | May 31, 2022 | 0 | 0.0% |
PROTHENA CORP PUBLIC LTD CO | March 01, 2022 | 1,805,038 | 3.9% |
Intersect ENT, Inc. | February 14, 2022 | 1,375,210 | 4.1% |
SeaSpine Holdings Corp | February 14, 2022 | 6,847,707 | 18.8% |
Oxford Immunotec Global PLCSold out | February 10, 2021 | 0 | 0.0% |
ENDOLOGIX INC /DE/ | February 14, 2020 | 816,236 | 4.6% |
Nuvectra CorpSold out | February 14, 2020 | 0 | 0.0% |
View First Light Asset Management, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13D/A | 2024-04-09 |
4 | 2024-04-08 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G | 2024-02-14 |
SC 13G | 2024-02-14 |
SC 13G | 2024-02-14 |
SC 13G | 2024-02-14 |
SC 13G | 2024-02-14 |
View First Light Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.